Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Misty R Jenkins

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Nature|December 13, 2023
Indigenous Australian genomes show deep structure and rich novel variationMatthew Silcocks, Ashley Farlow, Azure Hermes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 26, 2013
Rapid and unidirectional perforin pore delivery at the cytotoxic immune synapseJamie A Lopez, Misty R Jenkins, Jesse A Rudd-Schmidt, et al.
Oncoimmunology|November 21, 2015
CAR-T cells are serial killersAlexander J Davenport, Misty R Jenkins, David S Ritchie, et al.
The Journal of Experimental Medicine|March 4, 2015
Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse timeMisty R Jenkins, Jesse A Rudd-Schmidt, Jamie A Lopez, et al.
Clinical & Translational Immunology|March 9, 2023
Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastomaRebecca C Abbott, Melinda Iliopoulos, Katherine A Watson, et al.
The FEBS Journal|January 13, 2016
Serglycin determines secretory granule repertoire and regulates natural killer cell and cytotoxic T lymphocyte cytotoxicityVivien R Sutton, Amelia J Brennan, Sarah Ellis, et al.
NPJ Precision Oncology|June 14, 2025
Defining the extracellular matrix for targeted immunotherapy in adult and pediatric brain cancerZoe I Day, Samuel Roberts-Thomson, Yasmin J Nouri, et al.
Journal for Immunotherapy of Cancer|August 7, 2024
EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responsesLeesa Lertsumitkul, Melinda Iliopoulos, Stacie S Wang, et al.
Molecular Therapy Oncolytics|September 7, 2023
Endogenous H3.3K27M derived peptide restricted to HLA-A∗02:01 is insufficient for immune-targeting in diffuse midline gliomaStacie S Wang, Kirti Pandey, Katherine A Watson, et al.
Cancer Immunology Research|February 26, 2015
CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target CellsAlexander J Davenport, Misty R Jenkins, Ryan S Cross, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Nature|December 13, 2023
Indigenous Australian genomes show deep structure and rich novel variationMatthew Silcocks, Ashley Farlow, Azure Hermes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 26, 2013
Rapid and unidirectional perforin pore delivery at the cytotoxic immune synapseJamie A Lopez, Misty R Jenkins, Jesse A Rudd-Schmidt, et al.
Oncoimmunology|November 21, 2015
CAR-T cells are serial killersAlexander J Davenport, Misty R Jenkins, David S Ritchie, et al.
The Journal of Experimental Medicine|March 4, 2015
Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse timeMisty R Jenkins, Jesse A Rudd-Schmidt, Jamie A Lopez, et al.
Clinical & Translational Immunology|March 9, 2023
Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastomaRebecca C Abbott, Melinda Iliopoulos, Katherine A Watson, et al.
The FEBS Journal|January 13, 2016
Serglycin determines secretory granule repertoire and regulates natural killer cell and cytotoxic T lymphocyte cytotoxicityVivien R Sutton, Amelia J Brennan, Sarah Ellis, et al.
NPJ Precision Oncology|June 14, 2025
Defining the extracellular matrix for targeted immunotherapy in adult and pediatric brain cancerZoe I Day, Samuel Roberts-Thomson, Yasmin J Nouri, et al.
Journal for Immunotherapy of Cancer|August 7, 2024
EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responsesLeesa Lertsumitkul, Melinda Iliopoulos, Stacie S Wang, et al.
Molecular Therapy Oncolytics|September 7, 2023
Endogenous H3.3K27M derived peptide restricted to HLA-A∗02:01 is insufficient for immune-targeting in diffuse midline gliomaStacie S Wang, Kirti Pandey, Katherine A Watson, et al.
Cancer Immunology Research|February 26, 2015
CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target CellsAlexander J Davenport, Misty R Jenkins, Ryan S Cross, et al.
Pageof 5